ArticleScience translational medicine2018

MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation.

Praveen K Bommareddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.